ETC
JAZZ icon

Exchange Traded Concepts’s Jazz Pharmaceuticals JAZZ Stock Holding History

Exchange Traded Concepts’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152K Sell
805
-328
-29% -$57.3K ﹤0.01% 1288
2025
Q4 		$193K Buy
+1,133
New +$174K ﹤0.01% 1258
2025
Q3 		– Sell
-5,914
Closed -$628K – 1495
2025
Q2 		$628K Buy
5,914
+112
+2% +$12.2K 0.01% 861
2025
Q1 		$720K Sell
5,802
-1,243
-18% -$162K 0.01% 712
2024
Q4 		$868K Buy
7,045
+155
+2% +$18.3K 0.02% 619
2024
Q3 		$768K Buy
6,890
+1,233
+22% +$135K 0.02% 641
2024
Q2 		$604K Buy
5,657
+283
+5% +$31.1K 0.02% 645
2024
Q1 		$647K Buy
5,374
+770
+17% +$94.3K 0.02% 573
2023
Q4 		$566K Hold
4,604
– – 0.02% 585
2023
Q3 		$596K Buy
4,604
+284
+7% +$37.8K 0.02% 523
2023
Q2 		$536K Buy
4,320
+70
+2% +$9.42K 0.01% 595
2023
Q1 		$622K Sell
4,250
-826
-16% -$122K 0.02% 481
2022
Q4 		$809K Buy
5,076
+286
+6% +$41.9K 0.02% 334
2022
Q3 		$638K Buy
4,790
+4
+0.1% +$608 0.02% 344
2022
Q2 		$747K Buy
4,786
+402
+9% +$61.9K 0.02% 338
2022
Q1 		$682K Buy
4,384
+399
+10% +$57.9K 0.01% 420
2021
Q4 		$508K Sell
3,985
-233
-6% -$30.6K 0.01% 676
2021
Q3 		$549K Buy
4,218
+917
+28% +$139K 0.01% 508
2021
Q2 		$586K Buy
3,301
+129
+4% +$22.3K 0.02% 468
2021
Q1 		$521K Buy
3,172
+2,962
+1,410% +$487K 0.02% 448
2020
Q4 		$35K Buy
+210
New +$31.3K ﹤0.01% 775

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Exchange Traded Concepts's JAZZ Position: Q1 2026 in Review

Exchange Traded Concepts reduced its Jazz Pharmaceuticals (JAZZ) stake by 29% in Q1 2026, selling an estimated $57.3K and leaving 805 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Exchange Traded Concepts first reported a position in JAZZ in Q4 2020 and has held it in 21 quarters since. The position peaked at $868K in Q4 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Exchange Traded Concepts held 805 shares of Jazz Pharmaceuticals worth $152K as of Q1 2026.
  • Exchange Traded Concepts sold 328 Jazz Pharmaceuticals shares in Q1 2026, an estimated $57.3K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q1 2026, its #1288 holding.
  • Exchange Traded Concepts first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
  • Exchange Traded Concepts's Jazz Pharmaceuticals position peaked at $868K in Q4 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.